In 2013, bioMérieux celebrated a major milestone, our 50th anniversary. Our development during these years has been driven by a pioneering spirit and unrelenting commitment to improve public health worldwide. Today, in more than 150 countries through 41 subsidiaries and a large network of distributors, bioMérieux provides diagnostic solutions that improve patient health and ensure consumer safety.

We develop tests that bring high medical value for clinical decisions in the areas of infectious diseases, cardiovascular emergencies and targeted cancers. In industrial applications, we contribute to preventing contamination risks in agri-food, pharmaceutical and cosmetic products.

We also bring progress to laboratories: by increasing automation and improving data management, we are helping to reinforce the efficiency of healthcare structures, increase lab productivity, and reduce healthcare costs.

bioMérieux is determined to continue to play a pioneering role by innovating and designing the diagnostics of the future to address the major challenges for public health worldwide.

As a major player in the field of in vitro diagnostics, bioMérieux’s model for development is rooted in its commitment to serve public health. This longstanding commitment creates responsibilities that the company embraces, with a triple focus: Responsibility to society, to the workforce and to the environment